.

Central Drugs Requirement Control Organisation (Biological Department) issues advisory.

Convalescent plasma may be considered in COVID-19 patients with moderate disease who are not enhancing (oxygen requirement is progressively increasing) despite usage of steroids, noted a one-page advisory released by the Central Drugs Requirement Control Organisation (Biological Department), here on Wednesday.

Also read: Study on plasma treatment is ongoing: ICMR

The Health Ministry recently launched standards on medical management procedure for COVID-19 where specific t